NME's Averaging 1.5 Review Cycles to Gain Approval Today - New Report
New Industry Clinical Trial Starts hold At Record Levels in 2005 - New Report
US NME Submissions Hit Six-Year High in 2005 – New Report
CDER Complaint-Driven GCP Inspections Finding High Noncompliance Rates
No Evidence of “Cox-2” Effect in CDER
